Czech contributions to European cardiology - The European Heart Journal's perspective

Thomas F. Lüscher

Cor Vasa 2013, 55(1):e1-e5 | DOI: 10.1016/j.crvasa.2012.10.005  

2012: The first year of the new Cor et Vasa

Michael Aschermann

Cor Vasa 2013, 55(1):e6 | DOI: 10.1016/j.crvasa.2013.01.010  

Cardiology department hospitalization costs in patients with acute heart failure vary according to the etiology of the acute heart failure: Data from the AHEAD Core registry 2005-2009

Barbora Říhová, Jiří Pařenica, Jiří Jarkovský, Roman Miklík, Alexandra Šulcová, Simona Littnerová, Marián Felšöci, Petr Kala, Jindřich Špinar

Cor Vasa 2013, 55(1):e7-e14 | DOI: 10.1016/j.crvasa.2012.10.004  

Background: To assess the distribution of costs associated with Cardiology Unit hospitalization due to acute heart failure (AHF) and evaluate, from the perspective of the healthcare payer, the heterogeneity of resources use according to AHF etiology in patients from 2005 to 2009.Methods: The type and etiology of AHF was determined upon hospital admission. The cost of in-patient care was based on the individual hospital account of each patient (1759 patients in total; 58.7% male; mean age 71 years).Results: The median hospital stay was 7 days and the mean total cost of in-patient care was €3364. A Coronary Care Unit (CCU) stay was recorded...

Long-term results of catheter ablation for ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Martina Hrošová, Martin Fiala, Libor Škňouřil, Martin Pleva, Miloslav Dorda, Jan Chovančík, Štěpán Krawiec, Bronislav Holek, Jaroslav Januška

Cor Vasa 2013, 55(1):e15-e24 | DOI: 10.1016/j.crvasa.2012.11.014  

Aims: This study analyzed the arrhythmogenic substrates and mechanisms of ventricular tachycardia (VT), and long-term outcomes of catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). Methods: Nine patients (1 female, 40 ± 17 years) with ARVC/D and sustained monomorphic VT (SMVT) exhibiting left bundle branch block morphology of the QRS complex were studied. The diagnosis of ARVC/D was confirmed by means of echocardiography, magnetic resonance imaging, and electroanatomical mapping in all patients. Results: The patients underwent 10 ablation procedures. At the initial...

Cardiac amyloidosis: A comprehensive review

Michal Fikrle, Tomáš Paleček, Petr Kuchynka, Eduard Němeček, Lenka Bauerová, Jan Straub, Romana Ryšavá

Cor Vasa 2013, 55(1):e60-e75 | DOI: 10.1016/j.crvasa.2012.11.018  

Cardiac amyloidosis is characterized by clinically significant extracellular amyloid infiltration of the heart that is usually, but not always, associated with the involvement of other organs depending on the type of amyloid. Cardiac involvement represents the most important prognostic factor especially in AL amyloidosis and thus early diagnosis of amyloid heart disease is of utmost importance influencing further management of the patients. This review aims to broadly discuss pathogenesis, manifestation and complex diagnostics of amyloidosis with the main focus on amyloid cardiomyopathy. Also, the summary of current therapeutic options that have great...

Comments on the Summary of the ESC guidelines on the management of valvular heart disease (version 2012)

Jana Popelová, Miroslav Brtko, Petr Němec

Cor Vasa 2013, 55(1):e57-e59 | DOI: 10.1016/j.crvasa.2013.01.011  

Troponins in the definition of myocardial infarction after percutaneous coronary interventions

Marco Zimarino, Raffaele De Caterina

Cor Vasa 2013, 55(1):e82-e84 | DOI: 10.1016/j.crvasa.2012.10.001  

The recently updated Universal Definition of Myocardial infarction (MI) arbitrarily defined periprocedural MI (type 4a) by elevation of cardiac troponin (cTn) values > 5× the upper reference limit (URL) in patients with normal baseline values or a rise of cTn values > 20% if the baseline values are elevated, together with either angina or new ECG changes or angiographic loss of patency of a coronary artery or a side branch or persistent slow or no-flow or embolization, or imaging demonstration of new loss of viable myocardium.Although an association between CK-MB elevations and adverse prognosis after PCI has been documented, existing data...

Summary of the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Prepared by the Czech Society of Cardiology

Jaromír Hradec, Jiří Vítovec, Jindřich Špinar

Cor Vasa 2013, 55(1):e25-e40 | DOI: 10.1016/j.crvasa.2013.01.002  

Summary of the ESC guidelines on the management of valvular heart disease (version 2012). Prepared by the Czech Society of Cardiology

Jana Popelová, Miroslav Brtko, Petr Němec

Cor Vasa 2013, 55(1):e41-e56 | DOI: 10.1016/j.crvasa.2013.01.006  

Left ventricular perforation by a guidewire crossing a stenotic calcific aortic valve

Şenol Demircan, Hakan Altay

Cor Vasa 2013, 55(1):e76-e77 | DOI: 10.1016/j.crvasa.2012.05.016  

With the availability of better technology in catheterization techniques, perforation of myocardium during cardiac catheterization is a rare event. We report, a 65-year old male who developed this potentially life threatening complication, after several attempts were made to cross a heavily stenotic aortic valve. With this case presentation, we aim to call attention to this complication which we think will occur more frequently in the era of percutaneous aortic valve replacement.

Cardiac sarcoidosis as a cause of sudden death

Martin Hajšl, Pavel Sedloň, Miroslav Černohous, Martina Vašáková, Miloš Sokol, Miroslav Zavoral

Cor Vasa 2013, 55(1):e78-e81 | DOI: 10.1016/j.crvasa.2012.08.006  

Malcolm S. Thaler: EKG a jeho klinické využití

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2013, 55(1):107  

Radek Ptáček, Petr Bartůněk a kolektiv: Eutanazie - pro a proti

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2013, 55(1):108  

Nové rozšířené vydání knihy Richarda Češky

MUDr. Zuzana Zafarová

Cor Vasa 2013, 55(1):101-103  

Apixaban (Eliquis®) byl koncem roku 2012 registrován také v indikaci prevence cévních mozkových příhod a systémových embolií u nemocných s fibrilací síní

Jaromír Hradec

Cor Vasa 2013, 55(1):104-105  

Zpráva z 26. kongresu European Association for Cardio-Thoracic Surgery (Barcelona, Španělsko)

MUDr. Vojtěch Kurfirst

Cor Vasa 2013, 55(1):106 | DOI: 10.33678/cor.2013.008  

Zápis ze schůze výboru ČKS konané dne 18. 9. 2012 v Brně

P. Widimský, I. Pavézková

Cor Vasa 2013, 55(1):98-99  

Erratum k: "Catheter ablation for atrial fibrillation - Single center experience" [Cor et Vasa 54 (2012) 560-565]

Luděk Haman, Hana Dostálová, Petr Pařízek

Cor Vasa 2013, 55(1):95  

Zemřel prof. MUDr. Vlastimil Víšek, DrSc.

prof. MUDr. Pavel Gregor, DrSc., prof. MUDr. Petr Widimský, DrSc.

Cor Vasa 2013, 55(1):97  

Editorial Board

Editorial board

Cor Vasa 2013, 55(1):i | DOI: 10.1016/S0010-8650(13)00016-7